Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.

Blood advances - 14 Apr 2020

Dalton W Brian, Helmenstine Eric, Pieterse Lisa, Li Bing, Gocke Christopher D, Donaldson Joshua, Xiao Zhijian, Gondek Lukasz P, Ghiaur Gabriel, Gojo Ivana, Smith B Douglas, Levis Mark J, DeZern Amy E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to RNA Splicing
Share to RNA Splicing Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 32211880
DOI: 10.1182/bloodadvances.2019001127
PMCID: PMC7160262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing.PMID 32211880Read ↗

Clinical Characteristics and Molecular Profiling of SF3B1-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice.Semantic proximity Read ↗

SF3B1 mutations in spliceosome-driven tumorigenesis: From splicing dysregulation to signaling network rewiring and therapeutic targeting.Semantic proximity Read ↗

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patientsSemantic proximity Read ↗

Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations.Semantic proximity Read ↗

m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis.Semantic proximity Read ↗

Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of <i>SF3B1</i> mutationsSemantic proximity Read ↗

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.Semantic proximity Read ↗

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease processSemantic proximity Read ↗

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations.Semantic proximity Read ↗

Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.Semantic proximity Read ↗

SF3B1 mutant myelodysplastic syndrome: Recent advances.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.